Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment

Purpose: to evaluate the efficacy and safety of complex therapy of allergic conjunctivitis, including 0.2 % olopatodin. Patients and methods: In 40 allergic conjunctivitis (AK) patients were performed: assessment of the intensity of itching and tearing, as well as conjunctival hyperemia and follicul...

Full description

Saved in:
Bibliographic Details
Main Authors: S. V. Yanchenko, A. V. Malyshev, S. N. Sakhnov, A. V. Bukina
Format: Artigo
Language:Russo
Published: Ophthalmology Publishing Group 2019-10-01
Series:Oftalʹmologiâ
Subjects:
allergic conjunctivitis
0.2 % olopatadin
chronic blepharitis
Online Access:https://www.ophthalmojournal.com/opht/article/view/1018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items